Evidence map›Paper›PMID 31776194›Full record

ArticlePediatrics2019

Vaccine Oka Varicella Meningitis in Two Adolescents.

Whitney E Harrington, Sayonara Mató, Lauri Burroughs, Paul A Carpenter, Anne Gershon, D Scott Schmid, Janet A Englund

Erratum issuedOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in Pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Whitney E HarringtonSeattle Children's Hospital, Seattle, Washington; whitney.harrington@seattlechildrens.org.
Sayonara MatóRandall Children's Hospital at Legacy Emanuel, Portland, Oregon.
Lauri BurroughsSeattle Children's Hospital, Seattle, Washington.
Paul A CarpenterSeattle Children's Hospital, Seattle, Washington.
Anne GershonDepartment of Pediatrics, Vagelos School of Physicians and Surgeons, Columbia University, New York, New York; and.
D Scott SchmidViral Vaccine Preventable Diseases Branch, Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Janet A EnglundSeattle Children's Hospital, Seattle, Washington.
University of Washington · USCenters for Disease Control and Prevention · USColumbia University · USFred Hutch Cancer Center · USRandall Children's Hospital at Legacy Emanuel · USSeattle Children's Hospital · US

Funding

VZV in the enteric nervous system: pathogenesis and consequencesR01DK093094 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MICHAEL D GERSHON, Anne A. Gershon · 2011 to 2026
$5.9M
The Effect of Maternal Cells on Infant ImmunityK08AI135072 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI HARRINGTON, WHITNEY ELIZABETH · 2018 to 2022
$854k
NIAID NIH HHS K08 AI135072NIDDK NIH HHS R01 DK093094
6 · The paper itself

Abstract

The live-attenuated varicella vaccine, a routine immunization in the United States since 1995, is both safe and effective. Like wild-type varicella-zoster virus, however, vaccine Oka (vOka) varicella can establish latency and reactivate as herpes zoster, rarely leading to serious disease, particularly among immunocompromised hosts. Previous cases of reactivated vOka resulting in meningitis have been described in young children who received a single dose of varicella vaccine; less is known about vOka reactivation in older children after the 2-dose vaccine series. We present 2 adolescents with reactivated vOka meningitis, 1 immunocompetent and 1 immunocompromised, both of whom received 2 doses of varicella vaccine many years before as children. Pediatricians should be aware of the potential of vOka varicella to reactivate and cause clinically significant central nervous system disease in vaccinated children and adolescents.

Indexed as

Virus ActivationAcyclovirAdolescentAntiviral AgentsChickenpox VaccineHerpesvirus 3, HumanHumansImmunization ScheduleImmunocompetenceImmunocompromised HostMaleMeningitis, ViralAcyclovirAntiviral AgentsChickenpox Vaccine

Identifiers

PMID31776194
PMCPMC6889945
OpenAlexW2990688730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.